What is Aesthetic Solutions?
Aesthetic Solutions operates at the intersection of clinical dermatology and cosmetic innovation. The company provides a comprehensive suite of services, including injectable treatments, laser resurfacing, and body contouring, while simultaneously functioning as a premier research center. Their facility has been instrumental in the development and validation of numerous market-leading products, such as Botox and the Juvederm line. Under the leadership of Dr. Sue Ellen Cox, the company leverages its research-first approach to ensure its clinicians possess unparalleled expertise in emerging treatments. This commitment to evidence-based practice has earned the firm recognition as a top-tier provider in the Chapel Hill region, prioritizing patient safety and clinical efficacy above all else.
How much funding has Aesthetic Solutions raised?
Aesthetic Solutions has raised a total of $547K across 2 funding rounds:
Debt
$150K
Debt
$397K
Debt (2020): $150K with participation from PPP
Debt (2021): $397K led by PPP
Key Investors in Aesthetic Solutions
PPP
Public-Private Partnership
What's next for Aesthetic Solutions?
With the recent influx of capital, Aesthetic Solutions is well-positioned to scale its research operations and expand its clinical footprint. The company's strategic roadmap likely involves deepening its involvement in upcoming clinical trials for next-generation aesthetic devices and injectables. By continuing to train physicians for major industry bodies and pharmaceutical partners, the firm is poised to maintain its influence over the aesthetic medicine landscape. Future growth will likely focus on integrating advanced medical-grade skincare technologies and enhancing the patient experience through data-driven, personalized treatment protocols, ensuring the company remains at the forefront of the cosmetic surgery and dermatology sectors.
See full Aesthetic Solutions company page
